Dear Doctor Letter (Rote-Hand-Brief) on ▼Picato® (ingenol mebutate): caution when treating patients with a history of skin cancer
2019.09.23
Active substance: Ingenolmebutat
The pharmaceutical entrepreneur LEO Pharma informs about cases of squamous cell carcinoma in patients treated with inngenolmebutate.
Zum Risikobewertungsverfahren Picato®
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN